ASCO 2019 A tool to predict response to chemotherapy before bladder cancer surgery

ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery

10:10 EDT 4 Jun 2019 | ecancermedicalscience

University of Colorado Cancer Center led clinical trial data show that a predictive tool called COXEN may show which bladder cancer patients will respond to pre-surgical chemotherapy, a step towards allowing doctors to offer such chemotherapy to patients...

More From BioPortfolio on "ASCO 2019: A tool to predict response to chemotherapy before bladder cancer surgery"